Sökning: "Polyneuropathy"
Visar resultat 1 - 5 av 41 avhandlingar innehållade ordet Polyneuropathy.
1. Cryptogenic Polyneuropathy : Clinical, Environmental, And Genetic Studies
Sammanfattning : Objectives: The purpose of this medical thesis was to describe the clinical and neurophysiological features and to evaluate the health related quality of life (HR-QoL) in patients with cryptogenic polyneuropathy. We also wanted to investigate different occupational, and leisure time exposures as determinants for cryptogenic polyneuropathy, and to analyze whether polymorphisms for the null alleles of Glutathione S-Transferase Mu-1 (GSTM1), and Theta-1 (GSTT1), and a low activity genetic variation of epoxide hydrolase (EPHX) affect the risk of developing polyneuropathy. LÄS MER
2. Familial amyloidosis with polyneuropathy : studies of genetic factors modifying the phenotype of the disease
Sammanfattning : Background. Familial Amyloidosis with Polyneuropathy (FAP) is an autosomal dominantly inherited systemic amyloid disease. The disease is caused by mutations in the transthyretin (TTR) gene, where close to 100 different amyloidogenic mutations have been identified. LÄS MER
3. Familial amyloidosis with polyneuropathy : a clinical study based on patients living in northern Sweden
Sammanfattning : .... LÄS MER
4. Endemic ataxic polyneuropathy in Nigeria
Sammanfattning : Ataxic polyneuropathy is a neurological syndrome that was described from an endemic area in south-western Nigeria in the 1950s and 1960s. The major clinical features are sensory polyneuropathy, sensory gait ataxia, optic atrophy, and nerve deafness. LÄS MER
5. Polyneuropathy associated with monoclonal gammopathy : A clinical, neurophysiological and immunological study
Sammanfattning : This thesis is based upon clinical, neurophysiological, and immunological studies of polyneuropathy (symmetrical impairment of sensory and motor nerve function) in patients with monoclonal gammopathies, that is, patients characterized by proliferation of a plasma-cell clone secreting homogeneous immWloglobulins (M-component), which in some patients has serum antibody reactivity against peripheral nerve myelin.The prevalence of clinical polyneuropathy in patients with monoclonal gammopathy (n=3) was 36%, and the prevalence of all forms of polyneuropathy including patients with neurophysiological signs only andpatients with probable polyneuropathy (signs but no symptoms) was 58%. LÄS MER